Don't want ads? Subscribe or login now.

Pharma Biz Buys Animal Medicine Co. For Up To $520M

By Jade Martinez-Pogue · July 18, 2024, 3:23 PM EDT

Latham & Watkins LLP-advised animal health therapeutics company Invetx, which is currently owned by life sciences-focused investment management firm Novo Holdings, on Thursday announced plans to be bought by veterinary pharmaceuticals...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Jade

October 14, 2025
Ōura Valuation Soars To $11B After $900M Financing Round
October 02, 2025
Singaporean Biotech To Go Public Via $1.5B SPAC Merger
October 01, 2025
Weil, Morgan Lewis Steer Up To $900M Biopharma Purchase
September 23, 2025
AI Health Benefits Platform Secures $400M In New Funding
September 18, 2025
Group Of US Investors To Buy TikTok, Plus More Rumors
September 16, 2025
VarmX Partners With Biotech CSL In Deal Worth Up To $2.2B
September 02, 2025
Evernorth Health Plugs $3.5B Into Shields Health Solutions
August 25, 2025
AbbVie Nabs Depression Drug From Gilgamesh In $1.2B Deal
August 19, 2025
Sleep Fitness Biz Eight Sleep Raises $100M In VC Funding
August 12, 2025
Bayer Bets $1.3B On Kumquat Cancer Drug Candidate

Pharma Biz Buys Animal Medicine Co. For Up To $520M

Related Sections

Recent Articles By Jade